Medical nutrition is a kind of treatment especially for those who are overweight. It is for those with certain medical conditions as well. During treatment, the patient works closely with a licensed dietitian to create a personalized nutrition program just for them. A licensed dietitian can work with patients to solve their problems regarding their health.
During the process, individuals will be advised and counseled on how to change their lifestyle habits. This includes changing their eating habits and gradually replacing fatty foods with healthier choices such as fruits and vegetables. As a result, their intake of food will be less in quantity and more appropriate for the particular condition. The dietitians are there to help them and keep track of their progress. Once the individuals have reached their target weight, the dietitians can assist them in creating and implementing maintenance plans to maintain it.
Market Dynamics
The main factor influencing the medical nutrition market is rapid product launches by key players. The growing number of products launched by manufacturers in the market is expected to boost the market growth. For instance, in July 2019, Baxter Baxter International Inc. introduced Finomel, which is a ready-to-use bag with three chambers that can be used for parenteral nutrition in Europe. Moreover, partnerships and acquisition among market players are expected to augment the growth of the medical nutrition market. For instance, in 2019, Wellmetric and DSM joined forces to explore the efficacy of Wellmetrix's diagnostic platform for performing point-of-need and non-invasive measurements of health biomarkers.
However, the complications and side effects caused by medical nutrition products is the main restraining factor hindering the market growth. Moreover, lack of awareness of healthcare diet and adequate nutrition balance in middle and low-income groups is another factor hindering the growth of the medical nutrition market.
This market is distributed in five regions that include North America, Europe, Asia-Pacific, Africa, and the Middle East, and Latin America. Among these, North America is expected to hold a bigger share of the medical nutrition market owing to the rise of metabolic disorders and obesity in the region. For instance, according to the Trust for America's Health, in 2020 the U.S. adult obesity rate was 42.4% and this is the first time that the nation's obesity rate has passed the 40% mark and has revealed the obesity crisis of the region. The medical nutrition market in the Asia Pacific is estimated to witness significant growth owing to the prevalence of key players in the region and health campaigns by government and private authorities to make people aware of obesity and to treat it healthily.
Competitive Analysis
Major players operating in the global medical nutrition market include DSM, BASF SE, Sun Pharmaceuticals Inc., Fresenius Kabi AG, GlaxoSmithKline Plc, Nestlé, Danone S.A, Baxter, and Abbott.
In September 2020, Baxter announced that Clinimix E and Clinimix have been approved for treating patients who require parenteral nutrition. Likewise in April 2020, AYMES International launched a vegan oral medical nutrition with a product name AYMES ActaSolve Smoothie, as a dietary supplement for people suffering from malnutrition.
No comments:
Post a Comment